Van beleggers
voor beleggers
Uitgebreid zoeken

Beurscodes, betekenis en hulp bij zoeken

Europa

AEX
Euronext Amsterdam
BRU
Euronext Brussels
PSE
Euronext Paris
LIS
Euronext Lissabon
CHX
CBOE Europe, grote(re) EU aandelen
NAV
Investment Funds (NAV)

Noord-Amerika

NYS
New York Stock Exchange
OTC
CBOE BZX Exchange (US)
TSE
Toronto Stock Exchange

Kunt u een instrument niet vinden?

Zoek dan via de zogenaamde ISIN code. Elk instrument, aandeel etc. heeft een unieke code.

Kies vervolgens - wanneer er meerdere resultaten zijn - de notering op de beurs van uw keuze.

Waar vind ik die ISIN code?

Google de naam van het instrument, aandeel etc. met de toevoeging 'ISIN'.

Als zoeken op ISIN code geen resultaten oplevert hebben wij het instrument of aandeel niet in onze koersendatabase.

desktop iconMarkt Monitor
  • Word abonnee
  • Inloggen

    Inloggen

    • Geen account? Registreren

    Wachtwoord vergeten?
Home  /  Forum  /  ProQR Therapeutics  /  ProQR Therapeutics 2019

Ontvang nu dagelijks onze kooptips!

word abonnee

Aandeel ProQR Therapeutics NV OTC:PRQR.Q, NL0010872495

  • 2,000 22 apr 2024 22:00
  • +0,035 (+1,78%) Dagrange 1,970 - 2,100
  • 113.304 Gem. (3M) 209,3K

ProQR Therapeutics 2019

2.656 Posts
Pagina: «« 1 ... 74 75 76 77 78 ... 133 »» | Laatste | Omlaag ↓
  1. forum rang 6 Tom3 30 juli 2019 15:03
    Hi joell12, I am not pumping Arrowhead, I am only telling you that it is currently my most valuable holding. Until now it has not retracted as ProQR did. I only should have sold all ProQR when it was $20+ and buy it back at $ 8 as many have done here on this board. Amazing you don`t like Arrowhead. Is Regulus a better tittle to own??
  2. [verwijderd] 30 juli 2019 15:46
    you didnt say ARROWHEAD its your most valuable holding .. you said PROQR was once your biggest holding and now the smallest holding due to its decreasing in valuation. simply I pointed out that it doesnt make much sense because of your earlier posts by which you bought PROQR at 3 and something .. making it at 9 over 200% gain and adding to it the 1/3 you said you sold at 20 and rebought much more at around 10. you own also other companies like AFMD which went down in price. so overall how PROQR became your smallest valued investment? or did you ever own any of it ?

    as you pumping arrowhead .. there is almost no post on any board that you dont mention how good of a holding it is and how much you made on it and you expect it to go 10 times up.. meaning to a valuation thats like 25billion! these are your messages not mine.
  3. forum rang 7 4finance 30 juli 2019 15:50
    quote:

    Tom3 schreef op 30 juli 2019 15:03:

    Hi joell12, I am not pumping Arrowhead, I am only telling you that it is currently my most valuable holding. Until now it has not retracted as ProQR did. I only should have sold all ProQR when it was $20+ and buy it back at $ 8 as many have done here on this board. Amazing you don`t like Arrowhead. Is Regulus a better tittle to own??
    De discussie met die Joell12 vind ik een beetje kansloos ;-) Hij vliegt van links naar rechts met wat hij persoonlijk vindt. Ik zie nergens een onderbouwing....

  4. [verwijderd] 30 juli 2019 15:50
    as if I have to compare RGLS to ARWR and its your question is RGLS a better investment? yes I believe so when you consider than ARWR was 2 dollars 2 years ago and now 30 dollars .. currently at close to 3 billion dollar valuation while in phase 2

    RGLS is at a valuation of 15million dollars ,, its in phase 2 with Sanofi and may enter phase 2 in a big indication next year... and soon clinicals in HBV, GBM, HCV etc. I see a bigger potential vs risk in RGLS than in ARWR which could go down on any bad news .. for example a death or something no one expects. and has happened before so who knows.?

    RGLS at 15million could go up 10 times ,, ARWR at 2.5bill to go 10 times .. you see to me sounds harder and less probable.
  8. forum rang 6 Tom3 30 juli 2019 16:53
    quote:

    joel12 schreef op 30 juli 2019 15:58:

    aand now you are pissing me off Tom. i got a pissed of day.

    how stupid can you be dude? you say that you should had sold PRQR at 20.. while at the highest of ARWR you are still holding and pumping?

    dont you learn that in biotech you never know what will happen .. next? and you need to either

    1) sell , and sell again when things go up and buy lower
    2) or sell a bit or never sell and weather the storms for a bigger return down the line?

    so with ARWR dont get surprised that it may crash and on the arwr board you will again say.. I should had sold it ! if anything learn from PROQR experience
    or

    dont say it .. and concentrate on the value of the company long term.
    I am sorry that I wrote words you did not like but it doesn't give you the right to offend me. I wish you a lot of success. Goodbye.
  13. forum rang 6 Tom3 30 juli 2019 18:11
    Ja de grote verkoper gisteren was een incident. Je komt er nooit achter wie het was en welke motieven deze partij had. Ons fonds doet het wel beter dan het hier eerder genoemde Regulus. Wat ik er van begrepen heb, is die laatste een creatieve financieringsconstructie aangegaan waarbij er een groot gevaar is voor verwatering cq reverse split. Nou dan kan Daniel altijd nog naar Onno toe en dan is het fijn dat Daniel ook een pak aandelen ProQR bezit.
  15. forum rang 4 nb 30 juli 2019 19:36
    It seems everyone knows everything, has a meaning about things which can probably happen and if not, something has happend or is going to happen. So we live our lives every Day, waiting and expecting/hoping.
    Whatever.
    Joel, i certainly respect your input, things takes there time and Will not happen, often. Regulus, Who knows. Nothing is lost, when the input is low
  17. [verwijderd] 30 juli 2019 20:05
    YOU ARE 100% right!. btw , i am here for PROQR not RGLS ..
    prqr is my largest holding and am excited about the opportunity for what this company has and is set to do .. to the world!

    I follow it daily frankly because 1 thing: currently thats all I do.. I manage a small hedge fund. on this board I find sometimes .. sometimes,, some information that helps me with making trading decisions... or strenghtening/or not my conviction in the company.

    because of your post, and few others, I will post some interesting other things about Proqr in the coming days.. for example the fact that in October, Proqr has confirmed presentation at gene therapy day at Chardan. why has it confirmed days after its scheduled LCA results phase1/2?
    2 other companies also confirmed.. drna and arwr

    so will post more in coming days.
  19. [verwijderd] 30 juli 2019 20:30
    well.. thats all I do.. biotech investing and have done so for the past 5 years with lots of biiiiig ups and biiiig downs. so have been around.
    as to PROQR .. well if you remember the company did a big splash at its IPO .. there was a lot of talk around it to give VERTEX a fight in cystic fibrosis.
    i read into the technology, read into the short and long thesis and since almost from the beginning invested in the company.. and as time passed and I followed each individual move , each employee of the company.. its amazing and unique corporate structure, and culture I furthered and further invested in it.

    the first opportunity to sell and buy lower was when the cystic fibrosis data was revealed and the stock went up to 10 and then went down. of course the results where amazing but the company insiders have had a different strategic direction and they needed the cheap shares ... I continued to invest in the company and came to 1 of the annual shareholders meetings and saw with my own eyes the company that I invested in . its people especially and the dedication to what they do.

    at 20+ I knew the company is overpriced for its development phase.. and sold about 1/3 of t holding,, was afraid it may get bought out and didnt want to miss that. to be bought as the CEO always says he is a serial entrepreneur and and stated that he may sell the company if it benefits the patients.
    the share went down.. the insiders of course want the shares cheap.. and they hire alot thus need low strike prices.

    today I am convinced that the company has a technology that could change medicine as we know it. its just a matter of time .. and patience for the company to realize the vision. RNA is the way. and RNA Editing is the way to fix gene mutations.. especially in the brain.. Proqr is the leader in this field and the potential is really unlimited. the RNA editing btw was developed from the initial cystic fibrosis drug which also has an RNA editing MOA of sorts, but PROQR simply modularized it and productized it .. so it has been working on this from its early days until now...

    so thats the short and long story. Proqr is not widely known you are right, but I appreciate and respect that. its a strategy of the company not to pump itself up --- as it respects "in behalf of patients" motto
2.656 Posts
Pagina: «« 1 ... 74 75 76 77 78 ... 133 »» | Laatste |Omhoog ↑

Meedoen aan de discussie?

Word nu gratis lid of log in met je emailadres en wachtwoord.

Direct naar Forum

Premium drie voorbeelden van IEX Premium: de exclusieve content op de site, de app op een smartphone en IEX Magazine.

Benieuwd naar onze analyses en kooptips?

Word nu abonnee van IEX en krijg onbeperkt toegang tot onze (koop)tips en succesvolle modelportefeuilles. Nu 3 maanden voor slechts €19,95! Profiteer van 58% korting!

Word abonnee

Lees verder op het IEX netwerk Let op: Artikelen linken naar andere sites

Gesponsorde links

Meld u aan voor de dagelijkse Beursupdate

Dagelijks een update van het laatste beursnieuws en beleggingskansen in uw mailbox!